[Activity tarification and national guidelines for the proper use of expensive and innovative drugs in internal medicine]
Rev Med Interne
.
2008 Feb;29(2):84-6.
doi: 10.1016/j.revmed.2007.05.033.
Epub 2007 Jun 21.
[Article in French]
Author
N Dumarcet
PMID:
17624639
DOI:
10.1016/j.revmed.2007.05.033
No abstract available
Publication types
Editorial
MeSH terms
Clinical Protocols
Drug Labeling
Drugs, Investigational / therapeutic use*
France
Humans
Internal Medicine*
Legislation, Drug
Marketing of Health Services*
Practice Guidelines as Topic*
Risk Assessment
Substances
Drugs, Investigational